CTTH Quote, Financials, Valuation and Earnings

HealthWarehouse.com has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of 0.82%. CTT Pharmaceutical Holdings's return on equity of -- beat HealthWarehouse.com's return on equity of --.

CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand HealthWarehouse.com has an analysts' consensus of -- which suggests that it could grow by 550%. Given that HealthWarehouse.com has higher upside potential than CTT Pharmaceutical Holdings, analysts believe HealthWarehouse.com is more attractive than CTT Pharmaceutical Holdings.

CTT Pharmaceutical Holdings has a beta of 0.887, which suggesting that the stock is 11.348% less volatile than S&P 500. In comparison HealthWarehouse.com has a beta of 0.184, suggesting its less volatile than the S&P 500 by 81.581%.

CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. HealthWarehouse.com offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. HealthWarehouse.com pays out -- of its earnings as a dividend.

CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than HealthWarehouse.com quarterly revenues of $9M. CTT Pharmaceutical Holdings's net income of -- is lower than HealthWarehouse.com's net income of $73.8K. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while HealthWarehouse.com's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus 0.22x for HealthWarehouse.com. Usually stocks with elevated PS ratios are considered overvalued.

Synergy CHC has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of --. CTT Pharmaceutical Holdings's return on equity of -- beat Synergy CHC's return on equity of --.

CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Synergy CHC has an analysts' consensus of -- which suggests that it could fall by --. Given that CTT Pharmaceutical Holdings has higher upside potential than Synergy CHC, analysts believe CTT Pharmaceutical Holdings is more attractive than Synergy CHC.

CTT Pharmaceutical Holdings has a beta of 0.887, which suggesting that the stock is 11.348% less volatile than S&P 500. In comparison Synergy CHC has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Synergy CHC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. Synergy CHC pays out -- of its earnings as a dividend.

CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than Synergy CHC quarterly revenues of --. CTT Pharmaceutical Holdings's net income of -- is lower than Synergy CHC's net income of --. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while Synergy CHC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus -- for Synergy CHC. Usually stocks with elevated PS ratios are considered overvalued.

SunLink Health Systems has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of -9.16%. CTT Pharmaceutical Holdings's return on equity of -- beat SunLink Health Systems's return on equity of 12.24%.

CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand SunLink Health Systems has an analysts' consensus of -- which suggests that it could fall by --. Given that CTT Pharmaceutical Holdings has higher upside potential than SunLink Health Systems, analysts believe CTT Pharmaceutical Holdings is more attractive than SunLink Health Systems.

CTT Pharmaceutical Holdings has a beta of 0.887, which suggesting that the stock is 11.348% less volatile than S&P 500. In comparison SunLink Health Systems has a beta of 1.203, suggesting its more volatile than the S&P 500 by 20.282%.

CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SunLink Health Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. SunLink Health Systems pays out -- of its earnings as a dividend.

CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than SunLink Health Systems quarterly revenues of $7.3M. CTT Pharmaceutical Holdings's net income of -- is lower than SunLink Health Systems's net income of -$671K. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while SunLink Health Systems's PE ratio is 3.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus 0.19x for SunLink Health Systems. Usually stocks with elevated PS ratios are considered overvalued.

Walgreens Boots Alliance has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of -7.39%. CTT Pharmaceutical Holdings's return on equity of -- beat Walgreens Boots Alliance's return on equity of -46.98%.

CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Walgreens Boots Alliance has an analysts' consensus of $12.29 which suggests that it could grow by 10.05%. Given that Walgreens Boots Alliance has higher upside potential than CTT Pharmaceutical Holdings, analysts believe Walgreens Boots Alliance is more attractive than CTT Pharmaceutical Holdings.

CTT Pharmaceutical Holdings has a beta of 0.887, which suggesting that the stock is 11.348% less volatile than S&P 500. In comparison Walgreens Boots Alliance has a beta of 0.773, suggesting its less volatile than the S&P 500 by 22.656%.

CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Walgreens Boots Alliance offers a yield of 8.95% to investors and pays a quarterly dividend of $0.25 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. Walgreens Boots Alliance pays out -14.59% of its earnings as a dividend.

CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than Walgreens Boots Alliance quarterly revenues of $38.6B. CTT Pharmaceutical Holdings's net income of -- is lower than Walgreens Boots Alliance's net income of -$2.9B. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while Walgreens Boots Alliance's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus 0.06x for Walgreens Boots Alliance. Usually stocks with elevated PS ratios are considered overvalued.